Get started
Medipharm Labs CorporationMedipharm Labs CorporationMedipharm Labs Corporation

Medipharm Labs Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

MEDIF chart


Full chart

MEDIF upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪25.39 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0182 USD
Net income (FY)
‪−7.43 M‬ USD
Revenue (FY)
‪29.16 M‬ USD
Shares float
‪389.43 M‬
Beta (1Y)
1.04

Employees


Employees (FY)
161
Change (1Y)
−5 −3.01%
Revenue / Employee (1Y)
‪181.11 K‬ USD
Net income / Employee (1Y)
‪−46.16 K‬ USD

About MEDIPHARM LABS CORP


Sector
Process Industries
Industry
Agricultural Commodities/Milling
CEO
David A. Pidduck
Website
medipharmlabs.com
Headquarters
Barrie
Founded
2015
FIGI
BBG00M61H441
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. It focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon and Keith Strachan in 2015 and is headquartered in Barrie, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

MEDIF news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where MEDIF is featured.

See all sparks 


Check out other big names from the same industry as MEDIF.

Frequently Asked Questions


The current price of MEDIF is 0.0609 USD — it has decreased by −3.33% in the past 24 hours. Watch Medipharm Labs Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Medipharm Labs Corporation stocks are traded under the ticker MEDIF.
MEDIF stock has fallen by −1.77% compared to the previous week, the month change is a −21.97% fall, over the last year Medipharm Labs Corporation has showed a 5.91% increase.
MEDIF reached its all-time high on May 22, 2019 with the price of 5.6500 USD, and its all-time low was 0.0374 USD and was reached on Aug 5, 2024. View more price dynamics on MEDIF chart.
See other stocks reaching their highest and lowest prices.
MEDIF stock is 12.77% volatile and has beta coefficient of 1.04. Track Medipharm Labs Corporation stock price on the chart and check out the list of the most volatile stocks — is Medipharm Labs Corporation there?
Today Medipharm Labs Corporation has the market capitalization of ‪26.96 M‬, it has increased by 0.11% over the last week.
Yes, you can track Medipharm Labs Corporation financials in yearly and quarterly reports right on TradingView.
Medipharm Labs Corporation is going to release the next earnings report on May 19, 2025. Keep track of upcoming events with our Earnings Calendar.
MEDIF earnings for the last quarter are −0.0029 USD per share, whereas the estimation was −0.0024 USD resulting in a −23.53% surprise. The estimated earnings for the next quarter are −0.0025 USD per share. See more details about Medipharm Labs Corporation earnings.
Medipharm Labs Corporation revenue for the last quarter amounts to ‪10.62 M‬ USD, despite the estimated figure of ‪7.57 M‬ USD. In the next quarter, revenue is expected to reach ‪7.33 M‬ USD.
MEDIF net income for the last quarter is ‪−1.20 M‬ USD, while the quarter before that showed ‪−2.05 M‬ USD of net income which accounts for 41.50% change. Track more Medipharm Labs Corporation financial stats to get the full picture.
No, MEDIF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 25, 2025, the company has 161 employees. See our rating of the largest employees — is Medipharm Labs Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Medipharm Labs Corporation EBITDA is ‪−5.35 M‬ USD, and current EBITDA margin is −21.70%. See more stats in Medipharm Labs Corporation financial statements.
Like other stocks, MEDIF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Medipharm Labs Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Medipharm Labs Corporation technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Medipharm Labs Corporation stock shows the neutral signal. See more of Medipharm Labs Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.